Fortrea Holdings FTRE
NASDAQ FTRE
$18.27 -0.35 (-1.85%)
As of: Sep 4, 2026 · 11:50 AM EDT

Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Tax Provisions came in at $12.0 million in Q2 2026, up 185.71% YoY from $4.2 million in Q2 2025, and up 6.19% on a QoQ basis from $11.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Tax Provisions (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Tax Provisions data on file, last reported at $12.0 million in Q2 2026.

  • Quarterly Tax Provisions rose 185.71% year-over-year to $12.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.4 million (up 825.0% YoY) and the FY2025 annual result came in at $3.2 million, up 191.43% from the prior year.
  • Tax Provisions climbed to $12.0 million in Q2 2026, from $11.3 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $17.2 million in Q2 2022 to a low of -$17.3 million in Q3 2024.
  • A 5-year average of $3.5 million and a median of $4.2 million in 2025 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2023 — Tax Provisions sank 215.09% — and 2025, when it soared 263.41%.
  • Tracing FTRE's Tax Provisions over 5 years: stood at $5.3 million in 2022, then slumped by 215.09% to -$6.1 million in 2023, then soared by 83.61% to -$1.0 million in 2024, then tumbled by 210.0% to -$3.1 million in 2025, then soared by 487.1% to $12.0 million in 2026.
  • The last three Tax Provisions figures came in at $12.0 million (Q2 2026), $11.3 million (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn -59.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn 1.90 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn 12.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.00 Mn
Mar 31, 2026 11.30 Mn
Dec 31, 2025 -3.10 Mn
Sep 30, 2025 -12.80 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 14.90 Mn
Dec 31, 2024 -1.00 Mn
Sep 30, 2024 -17.30 Mn
Jun 30, 2024 10.70 Mn
Mar 31, 2024 4.10 Mn
Dec 31, 2023 -6.10 Mn
Sep 30, 2023 -5.80 Mn
Jun 30, 2023 11.60 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 5.30 Mn
Sep 30, 2022 13.60 Mn
Jun 30, 2022 17.20 Mn